Pharmacovigilance And Drug Safety Software Market Worth $314.11 Million By 2030

Pharmacovigilance And Drug Safety Software Market Growth & Trends

The global pharmacovigilance and drug safety software market size is anticipated to reach USD 314.11 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 6.8% from 2023 to 2030. The key factors driving the market growth include the increasing need to track and manage adverse drug reactions (ADR), comply with regulatory norms, increase adoption by end-users, interoperability, and product upgrades by key companies. In February 2022, Oracle’sArgus (for safety management) and Clinical One (for clinical trial management) were implemented by Clinixir-a Thailand-based CRO.

Various end-users such as pharmaceutical, and biotechnology companies, are adopting pharmacovigilance and drug safety software for cost reduction and minimizing operational expenses by gradually shifting from being fully integrated pharmaceutical companies to sharing costs by collaborating with service providers. Outsourcing helps increase internal resource flexibility, improves timelines, and results in better outcomes in the short as well as long term. Outsourcing also helps achieve better pharmacovigilance (PV) through regulatory compliance, higher quality, better productivity, and improved strategic outcomes. This is expected to fuel market growth.

Pharmacovigilance and drug safety software vendors, in an attempt to ensure sustainability, are providing customized and end-to-end solutions to meet consumer needs. These vendors are also incorporating integrated technologies such as electronic data capture, AI, and interoperability, among others to enhance their offerings. Moreover, the combined pressures of volume, cost, and heightened demand for analytics are propelling industry stakeholders to adopt advanced technology to support their pharmacovigilance activities. Also, the fact that service providers are now operating via a flexible and variable pricing structure and achieving operational excellence through constant product updates is expected to boost usage rates over the forecast period.

 Request a free sample copy or view the report summary: Pharmacovigilance And Drug Safety Software Market Report

Pharmacovigilance And Drug Safety Software Market Report Highlights

• The market was valued at USD 7.8 billion in 2022 and is expected to expand at a CAGR of 10.30% during the forecast period

• By functionality, the signal management segment held the largest revenue share in 2022. This growth is driven by the increasing use of machine learning and AI in signal detection and reporting

• Based on delivery mode, the on-demand segment dominated the market in 2022. This is owing to the greater flexibility offered by an on-demand software in terms of price, functionality, and scalability

• Based on end-use, the CROs and BPO segments are slated to witness lucrative growth owing to increasing adoption by outsourcing companies to curb healthcare costs

• By region, North America dominated the market in 2022 while the APAC market is anticipated to grow the fastest in the coming years. Asian countries, especially India and China, are also expected to observe remarkable growth in the coming years

• The market is relatively competitive owing to the presence of global multinational players. It is also consolidated to a certain extent with large multinational companies holding a notable share of the market

Pharmacovigilance And Drug Safety Software Market Segmentation

Grand View Research has segmented the global pharmacovigilance and drug safety software market based on functionality, delivery mode, end-use, and region:

Pharmacovigilance and Drug Safety Software Functionality Outlook (Revenue, USD Million, 2017 - 2030)

• Case data collection and management

• Adverse event reporting and analysis

• Signal detection and other safety risk assessment

Pharmacovigilance and Drug Safety Software Delivery Mode Outlook (Revenue, USD Million, 2017 - 2030)

• On Premise

• On Demand

Pharmacovigilance and Drug Safety Software End Use Outlook (Revenue, USD Million, 2017 - 2030)

• Healthcare Companies (Pharmaceuticals & Biotechnology Companies)

• CROs/BPOs or PV service providers when outsourced.

• Others

Pharmacovigilance and Drug Safety Software Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Sweden

  • Denmark

  • Norway

• Asia Pacific

  • China

  • India

  • Japan

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Pharmacovigilance And Drug Safety Software Market

• IQVIA

• Accenture

• Cognizant

• Laboratory Corporation of America Holdings

• IBM

• ArisGlobal

• ICON Plc.

• Capgemini

• Oracle

• Parexel International Corporation